SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 413.94 |
| Enterprise Value ($M) | 341.94 |
| Book Value ($M) | 255.27 |
| Book Value / Share | 4.44 |
| Price / Book | 1.62 |
| NCAV ($M) | 68.47 |
| NCAV / Share | 1.19 |
| Price / NCAV | 6.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.73 |
| Current Ratio | 4.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 164.41 |
| Assets | 351.21 |
| Liabilities | 95.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Phoenix Holdings Ltd. | 7.20 | -4.07 | |
| 13G/A | Gov Financial Holdings Ltd. | 6.15 | -1.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 19,526 | 121,299 | 16.10 | |
| 25,620 | 237,695 | 10.78 | |
| 89,184 | 474,110 | 18.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IRWD – Ironwood Pharmaceuticals, Inc. | ITCI – Intra-Cellular Therapies, Inc. |
| JAZZ – Jazz Pharmaceuticals plc | KNSA – Kiniksa Pharmaceuticals, Ltd. |
| KPTI – Karyopharm Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io